DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing

BALTIMORE, Oct. 2 MD-laser-skin-therapy


- Dr. Robert Weiss, Director of Maryland Laser, Skin and Vein Institute, Introduces DOT Therapy to his practice -



 

BALTIMORE, Oct. 2 /PRNewswire/ -- Robert Weiss, M.D., board certified dermatologist, is among the first physicians in the U.S. to offer his patients DOT Therapy (Dermal Optical Thermolysis), the latest, state-of-the-art procedure in laser skin resurfacing. Dr. Weiss is an internationally renowned dermatologist, who is in private practice in Hunt Valley, Md. and is also Director, Maryland Laser, Skin and Vein Institute.



According to Dr. Weiss, "DOT Therapy is a highly effective tool for reversing signs of aging of the skin. The key is in the way the engineers have designed the laser application for the skin. And, skin numbing cream is all that is needed."



DOT Therapy has taken laser skin rejuvenation to a whole new level.



This new procedure precisely delivers CO2 laser energy targeting the face, neck, decolletage, hand and arms, opening up whole new areas for laser rejuvenation.




DOT Therapy effectively improves sun damage, brown spots, wrinkles, fine lines, and acne scarring with little downtime or discomfort -- usually in minutes. 




Patients are pleased with the face and body skin tightening and improvement of crepe skin.   




The SmartXide DOT laser system has the unique capability to deliver a customized pattern of tiny, micro-sized dots, rather than treating the entire skin surface, so healing is fast.   




DOT Therapy has been introduced through an alliance between Eclipsemed, Ltd., one of the country's leading aesthetic laser distributors, and DEKA, one of the world's largest laser manufacturers. The SmartXide DOT system is an advanced CO2 (carbon dioxide) laser. The CO2 laser is the most common type of laser used for skin resurfacing: thoroughly proven and tested.  CO2 lasers of the past covered the entire surface of the skin, resulting in a significant amount of downtime to heal, discomfort for the patient and prolonged redness of the skin. In addition, the old CO2 lasers could not treat non-facial areas like the neck and decolletage easily because skin in these areas did not heal as well as the face.  DOT Therapy has received clearance from the Food & Drug Administration.   



For more information, please visit www.dottherapy.com or www.eclipsemed.com.



Press Contact: Wendy Maurice, wendy@trentandcompany.com

Marketing Contact: Michelle Peters, mpeters@eclipsemed.com







SOURCE  Eclipsemed, Ltd.